Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04269200
Brief Title: Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer (DUO-E)

First Submitted : February 10, 2020
First Submitted that Met QC Criteria : February 12, 2020
First Posted : February 13, 2020

Last Update Submitted that Met QC Criteria : July 7, 2021
Last Update Posted : July 8, 2021